The latest QCI Interpret 2024 Release enhances performance of high-throughput NGS labs, improving turn-around time, diagnostic yield and quality of...

The industry-leading NGS variant interpretation and reporting software now includes a new Clinical Validity feature, Dynamic Candidate Disease Identification, NICE...

Discover more about the latest QCI update and how the platform simplifies and accelerates NGS variant analysis, interpretation, and reporting...

Next-generation sequencing (NGS) has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors...

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One...

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN...

We're launching our new Sample to Insight QIAact Myeloid DNA UMI Panel! We are unveiling our new Sample to Insight...

As the number of genomes sequenced each day continues to skyrocket and healthcare professionals increasingly rely on genetic information to...

The recent AMP Europe 2018 conference was a wonderful chance to catch up with old friends and establish new relationships—our...

This week is the Advances in Genome Biology & Technology annual conference, taking place this year in Orlando. The QIAGEN...